Impact of gender in patients with continuous-flow left ventricular assist device therapy in end-stage heart failure.
Alina ZubarevichMarcin SzczechowiczAnja OsswaldArian Arjomandi RadRobert VardanyanMichel Pompeu Bo SáJef Van den EyndeBastian SchmackDaniel WendtAchim KochNikolaus PizanisMarkus KamlerArjang RuhparwarAlexander WeymannKonstantin ZhigalovPublished in: The International journal of artificial organs (2021)
Durable continuous flow left ventricular assist devices as a bridge to transplantation or recovery in female patients are associated with a higher risk of acute kidney injury requiring RRT and are at a higher risk of LVAD-thrombosis. Nevertheless, survival rates between genders are similar.
Keyphrases
- left ventricular assist device
- heart failure
- left ventricular
- acute kidney injury
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- cardiac surgery
- peritoneal dialysis
- mental health
- mitral valve
- acute myocardial infarction
- atrial fibrillation
- stem cells
- coronary artery disease
- aortic valve
- free survival
- transcatheter aortic valve replacement